Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study reveals how much pain relief actually matters for period cramps

NCT ID NCT06835036

Knowledge-focused Sponsor: Artvin Coruh University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at 100 women with primary dysmenorrhea (painful periods) to find out what amount of pain reduction is truly meaningful to them. Participants did an 8-week exercise program, and researchers measured pain and other symptoms using standard questionnaires. The goal is to help future studies set better targets for what counts as real improvement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Exercise treatment (functional exercise programme 3 days/week for 8 weeks)
What this could lead to
If successful, this study will help doctors and researchers know how much pain relief is meaningful for women with period cramps, improving future treatment studies.
What could go wrong
This is a completed observational study with only 100 participants, so results may not apply to all women. It does not test a new treatment, only how to measure improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Feb 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of PD according to the "No. 345-Primary Dysmenorrhea Consensus Guideline", * Pain level of three or more according to VAS during activity (moderate to severe pain), * Patients aged 18-35 years (when PD becomes more prevalent), * Regular menstrual cycle with a duration of 28±7 days, * Nulliparity. Exclusion Criteria: * Historical background of chronic urogenital infections or drug use, * Pregnancy, * Secondary dysmenorrhoea caused by gynaecological conditions such as endometriosis, adenomyosis and uterine fibroids.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menstrual discomfort are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dysmenorrhea Pain primary dysmenorrhea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Menstrual discomfort Pain Primary dysmenorrhea

Contacts and locations

Locations

  • Zeynep Yıldız Kızkın

    Artvin, 08000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.